Travere Therapeutics to Report Second Quarter 2025 Financial Results

Go back to Travere Therapeutics to Report Second Quarter 2025 Financial Results
(NASDAQ: TVTX) Delayed: 67.23 +1.52 (2.31%)
Previous Close $65.71    52 Week High
Open $66.37    52 Week Low
Day High $67.82    P/E N/A 
Day Low $65.76    EPS
Volume 1,085,748